Fibrocytes are not an essential source of type i collagen during lung fibrosis

Journal of Immunology

Volumn 193, Issue 10, 2014, Pages 5229-5239

  Kleaveland, Kathryn R ^a   Velikoff, Miranda ^a   Yang, Jibing ^a   Agarwal, Manisha ^a   Rippe, Richard A ^b   Moore, Bethany B ^a   Kim, Kevin K ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; GREEN FLUORESCENT PROTEIN; BLEOMYCIN;

ANIMAL EXPERIMENT; ARTICLE; COL1A1 GENE; CONTROLLED STUDY; ENDOCYTOSIS; FIBROCYTE; FIBROGENESIS; GENE; GENE DELETION; GENE FUNCTION; GENE SYNTHESIS; HEMATOPOIETIC CELL; LUNG FIBROSIS; MESENCHYME CELL; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CHEMICALLY INDUCED; DEFICIENCY; GENE EXPRESSION; GENETICS; METABOLISM; PATHOLOGY; PROTEIN TRANSPORT; REPORTER GENE; STROMA CELL; TRANSGENIC MOUSE;

ANIMALS; BLEOMYCIN; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; COLLAGEN TYPE I; GENE EXPRESSION; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; MICE; MICE, TRANSGENIC; PROMOTER REGIONS, GENETIC; PROTEIN TRANSPORT; PULMONARY FIBROSIS; STROMAL CELLS;

EID: 84910149102     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400753     Document Type: Article

References (59)

1. 2000. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am. J. Respir. Crit. Care Med. 161: 646-664.
2. American Thoracic Society, and European Respiratory Society. 2002. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001.[Published erratum appears in 2002 Am. J. Respir. Crit. Care Med. 166: 426.] Am. J. Respir. Crit. Care Med. 165: 277-304.
3. Selman, M., T. E. King, and A. Pardo, American Thoracic Society, European Respiratory Society, American College of Chest Physicians. 2001. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 134: 136-151.
4. Thannickal, V. J., G. B. Toews, E. S. White, J. P. Lynch, III, and F. J. Martinez. 2004. Mechanisms of pulmonary fibrosis. Annu. Rev. Med. 55: 395-417.
5. Meltzer, E. B., and P. W. Noble. 2008. Idiopathic pulmonary fibrosis. Orphanet J. Rare Dis. 3: 8.
6. Scotton, C. J., and R. C. Chambers. 2007. Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 132: 1311-1321.
7. Kalluri, R., and E. G. Neilson. 2003. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112: 1776-1784.
8. Kalluri, R., and R. A. Weinberg. 2009. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119: 1420-1428.
9. Zeisberg, E. M., O. Tarnavski, M. Zeisberg, A. L. Dorfman, J. R. McMullen, E. Gustafsson, A. Chandraker, X. Yuan, W. T. Pu, A. B. Roberts, et al. 2007. Endothelial-To-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13: 952-961.
10. Selman, M., and A. Pardo. 2006. Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proc. Am. Thorac. Soc. 3: 364-372.
11. Hashimoto, N., S. H. Phan, K. Imaizumi, M. Matsuo, H. Nakashima, T. Kawabe, K. Shimokata, and Y. Hasegawa. 2010. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 43: 161-172.
12. Humphreys, B. D., S. L. Lin, A. Kobayashi, T. E. Hudson, B. T. Nowlin, J. V. Bonventre, M. T. Valerius, A. P. McMahon, and J. S. Duffield. 2010. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. 176: 85-97.
13. Hung, C., G. Linn, Y. H. Chow, A. Kobayashi, K. Mittelsteadt, W. A. Altemeier, S. A. Gharib, L. M. Schnapp, and J. S. Duffield. 2013. Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 188: 820-830.
14. LeBleu, V. S., G. Taduri, J. O'Connell, Y. Teng, V. G. Cooke, C. Woda, H. Sugimoto, and R. Kalluri. 2013. Origin and function of myofibroblasts in kidney fibrosis. Nat. Med. 19: 1047-1053.
15. Kasai,H., J. T. Allen, R.M. Mason, T. Kamimura, and Z. Zhang. 2005.TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir. Res. 6: 56.
16. Willis, B. C., and Z. Borok. 2007. TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 293: L525-L534.
17. Kleaveland, K. R., B. B. Moore, and K. K. Kim. 2014. Paracrine functions of fibrocytes to promote lung fibrosis. Expert Rev. Respir. Med. 8: 163-172.
18. Bucala, R., L. A. Spiegel, J. Chesney, M. Hogan, and A. Cerami. 1994. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol. Med. 1: 71-81.
19. Chesney, J., M. Bacher, A. Bender, and R. Bucala. 1997. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc. Natl. Acad. Sci. USA 94: 6307-6312.
20. Chesney, J., C. Metz, A. B. Stavitsky, M. Bacher, and R. Bucala. 1998. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J. Immunol. 160: 419-425.
21. Gomperts, B. N., and R. M. Strieter. 2007. Fibrocytes in lung disease. J. Leukoc. Biol. 82: 449-456.
22. Moore, B. B., J. E. Kolodsick, V. J. Thannickal, K. Cooke, T. A. Moore, C. Hogaboam, C. A.Wilke, and G. B. Toews. 2005. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am. J. Pathol. 166: 675-684.
23. Moore, B. B., L. Murray, A. Das, C. A.Wilke, A. B. Herrygers, and G. B. Toews. 2006. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am. J. Respir. Cell Mol. Biol. 35: 175-181.
24. Phillips, R. J., M. D. Burdick, K. Hong, M. A. Lutz, L. A. Murray, Y. Y. Xue, J. A. Belperio, M. P. Keane, and R. M. Strieter. 2004. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J. Clin. Invest. 114: 438-446.
25. Madsen, D. H., S. Ingvarsen, H. J. Jürgensen, M. C. Melander, L. Kjøller, A. Moyer, C. Honoré, C. A. Madsen, P. Garred, S. Burgdorf, et al. 2011. The non-phagocytic route of collagen uptake: a distinct degradation pathway. J. Biol. Chem. 286: 26996-27010.
26. Bianchetti, L., M. Barczyk, J. Cardoso, M. Schmidt, A. Bellini, and S. Mattoli. 2012. Extracellular matrix remodelling properties of human fibrocytes. J. Cell. Mol. Med. 16: 483-495.
27. Kim, K. K., M. C. Kugler, P. J. Wolters, L. Robillard, M. G. Galvez, A. N. Brumwell, D. Sheppard, and H. A. Chapman. 2006. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc. Natl. Acad. Sci. USA 103: 13180-13185.
28. Zeisberg, M., and R. Kalluri. 2004. The role of epithelial-To-mesenchymal transition in renal fibrosis. J. Mol. Med. 82: 175-181.
29. Iwano, M., D. Plieth, T. M. Danoff, C. Xue, H. Okada, and E. G. Neilson. 2002. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110: 341-350.
30. DeMaio, L., S. T. Buckley, M. S. Krishnaveni, P. Flodby, M. Dubourd, A. Banfalvi, Y. Xing, C. Ehrhardt, P. Minoo, B. Zhou, et al. 2012. Ligandindependent transforming growth factor-b type I receptor signalling mediates type I collagen-induced epithelial-mesenchymal transition. J. Pathol. 226: 633-644.
31. Tanjore, H., X. C. Xu, V. V. Polosukhin, A. L. Degryse, B. Li, W. Han, T. P. Sherrill, D. Plieth, E. G. Neilson, T. S. Blackwell, and W. E. Lawson. 2009. Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am. J. Respir. Crit. Care Med. 180: 657-665.
32. Rock, J. R., C. E. Barkauskas, M. J. Cronce, Y. Xue, J. R. Harris, J. Liang, P. W. Noble, and B. L. Hogan. 2011. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc. Natl. Acad. Sci. USA 108: E1475-E1483.
33. Phan, S. H. 2008. Biology of fibroblasts and myofibroblasts. Proc. Am. Thorac. Soc. 5: 334-337.
34. Schmidt, M., G. Sun, M. A. Stacey, L. Mori, and S. Mattoli. 2003. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J. Immunol. 171: 380-389.
35. Hashimoto, N., H. Jin, T. Liu, S. W. Chensue, and S. H. Phan. 2004. Bone marrowderived progenitor cells in pulmonary fibrosis. J. Clin. Invest. 113: 243-252.
36. Zhang, K., M. D. Rekhter, D. Gordon, and S. H. Phan. 1994. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis: a combined immunohistochemical and in situ hybridization study. Am. J. Pathol. 145: 114-125.
37. Yang, J., S. E. Wheeler, M. Velikoff, K. R. Kleaveland, M. J. LaFemina, J. A. Frank, H. A. Chapman, P. J. Christensen, and K. K. Kim. 2013. Activated alveolar epithelial cells initiate fibrosis through secretion of mesenchymal proteins. Am. J. Pathol. 183: 1559-1570.
38. de Boer, J., A. Williams, G. Skavdis, N. Harker, M. Coles, M. Tolaini, T. Norton, K. Williams, K. Roderick, A. J. Potocnik, and D. Kioussis. 2003. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur. J. Immunol. 33: 314-325.
39. Yata, Y., A. Scanga, A. Gillan, L. Yang, S. Reif, M. Breindl, D. A. Brenner, and R. A. Rippe. 2003. DNase I-hypersensitive sites enhance α1(I) collagen gene expression in hepatic stellate cells. Hepatology 37: 267-276.
40. Bhan, U., G. Trujillo, K. Lyn-Kew, M. W. Newstead, X. Zeng, C. M. Hogaboam, A. M. Krieg, and T. J. Standiford. 2008. Toll-like receptor 9 regulates the lung macrophage phenotype and host immunity in murine pneumonia caused by Legionella pneumophila. Infect. Immun. 76: 2895-2904.
41. Ballinger, M. N., R. Paine, III, C. H. Serezani, D. M. Aronoff, E. S. Choi, T. J. Standiford, G. B. Toews, and B. B. Moore. 2006. Role of granulocyte macrophage colony-stimulating factor during gram-negative lung infection with Pseudomonas aeruginosa. Am. J. Respir. Cell Mol. Biol. 34: 766-774.
42. Atabai, K., S. Jame, N. Azhar, A. Kuo, M. Lam, W. McKleroy, G. Dehart, S. Rahman, D. D. Xia, A. C. Melton, et al. 2009. Mfge8 diminishes the severity of tissue fibrosis in mice by binding and targeting collagen for uptake by macrophages. J. Clin. Invest. 119: 3713-3722.
43. Domingo-Gonzalez, R., S. Katz, C. H. Serezani, T. A. Moore, A. M. Levine, and B. B. Moore. 2013. Prostaglandin E2-induced changes in alveolar macrophage scavenger receptor profiles differentially alter phagocytosis of Pseudomonas aeruginosa and Staphylococcus aureus post-bone marrow transplant. J. Immunol. 190: 5809-5817.
44. Lee, T. H., W. McKleroy, A. Khalifeh-Soltani, S. Sakuma, S. Lazarev, K. Riento, S. L. Nishimura, B. J. Nichols, and K. Atabai. 2014. Functional genomic screen identifies novel mediators of collagen uptake. Mol. Biol. Cell 25: 583-593.
45. Kim, K. K., Y. Wei, C. Szekeres, M. C. Kugler, P. J. Wolters, M. L. Hill, J. A. Frank, A. N. Brumwell, S. E. Wheeler, J. A. Kreidberg, and H. A. Chapman. 2009. Epithelial cell a3b1 integrin links b-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J. Clin. Invest. 119: 213-224.
46. Yang, J., M. Velikoff, E. Canalis, J. C. Horowitz, and K. K. Kim. 2014. Activated alveolar epithelial cells initiate fibrosis through autocrine and paracrine secretion of connective tissue growth factor. Am. J. Physiol. Lung Cell. Mol. Physiol. 306: L786-L796.
47. Bauman, K. A., S. H. Wettlaufer, K. Okunishi, K. M. Vannella, J. S. Stoolman, S. K. Huang, A. J. Courey, E. S. White, C. M. Hogaboam, R. H. Simon, et al. 2010. The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice. J. Clin. Invest. 120: 1950-1960.
48. Bundesmann, M. M., T. E. Wagner, Y. H. Chow, W. A. Altemeier, T. Steinbach, and L. M. Schnapp. 2012. Role of urokinase plasminogen activator receptor-associated protein in mouse lung. Am. J. Respir. Cell Mol. Biol. 46: 233-239.
49. Leitinger, B., and E. Hohenester. 2007. Mammalian collagen receptors. Matrix Biol. 26: 146-155.
50. Kjøller, L., L. H. Engelholm, M. Høyer-Hansen, K. Danø, T. H. Bugge, and N. Behrendt. 2004. uPARAP/endo180 directs lysosomal delivery and degradation of collagen IV. Exp. Cell Res. 293: 106-116.
51. McKleroy, W., T. H. Lee, and K. Atabai. 2013. Always cleave up your mess: targeting collagen degradation to treat tissue fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 304: L709-L721.
52. Myllyharju, J., and K. I. Kivirikko. 2004. Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet. 20: 33-43.
53. Cowper, S. E., and R. Bucala. 2003. Nephrogenic fibrosing dermopathy: suspect identified, motive unclear. Am. J. Dermatopathol. 25: 358.
54. Nihlberg, K., K. Larsen, A. Hultgårdh-Nilsson, A. Malmström, L. Bjermer, and G. Westergren-Thorsson. 2006. Tissue fibrocytes in patients with mild asthma: a possible link to thickness of reticular basement membrane? Respir. Res. 7: 50.
55. Bellini, A., M. A. Marini, L. Bianchetti, M. Barczyk, M. Schmidt, and S. Mattoli. 2012. Interleukin (IL)-4, IL-13, and IL-17A differentially affect the profibrotic and proinflammatory functions of fibrocytes from asthmatic patients. Mucosal Immunol. 5: 140-149.
56. Isgrò, M., L. Bianchetti, M. A. Marini, and S. Mattoli. 2013. Involvement of fibrocytes in allergen-induced T cell responses and rhinovirus infections in asthma. Biochem. Biophys. Res. Commun. 437: 446-451.
57. Kisseleva, T., H. Uchinami, N. Feirt, O. Quintana-Bustamante, J. C. Segovia, R. F. Schwabe, and D. A. Brenner. 2006. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J. Hepatol. 45: 429-438.
58. Dominici, M., K. Le Blanc, I. Mueller, I. Slaper-Cortenbach, F. Marini, D. Krause, R. Deans, A. Keating, Dj. Prockop, and E. Horwitz. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
59. Suga, H., R. C. Rennert, M. Rodrigues, M. Sorkin, J. P. Glotzbach, M. Januszyk, T. Fujiwara, M. T. Longaker, and G. C. Gurtner. 2014. Tracking the elusive fibrocyte: identification and characterization of collagen-producing hematopoietic lineage cells during murine wound healing. Stem Cells 32: 1347-1360.